CNL Healthcare Properties, Inc. financial data

Symbol
CHTH on OTC
Location
450 South Orange Avenue, Orlando, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 85.8 % +3.75%
Return On Equity -1.99 % +40.7%
Return On Assets -0.92 % +39.7%
Operating Margin 8.59 % +31.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 175M shares 0%
Common Stock, Shares, Outstanding 175M shares 0%
Entity Public Float 1.1B USD -8.33%
Common Stock, Value, Issued 1.74M USD 0%
Weighted Average Number of Shares Outstanding, Basic 174M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 174M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 379M USD +7.49%
Revenue from Contract with Customer, Excluding Assessed Tax 351M USD +7.98%
General and Administrative Expense 8.87M USD -1.02%
Costs and Expenses 346M USD +5.14%
Operating Income (Loss) 32.6M USD +41.1%
Nonoperating Income (Expense) -44M USD -1.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.5M USD +43.2%
Income Tax Expense (Benefit) 689K USD +15.8%
Net Income (Loss) Attributable to Parent -12.2M USD +41.6%
Earnings Per Share, Basic 0 USD/shares +53.8%
Earnings Per Share, Diluted 0 USD/shares +53.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 53.2M USD +8.35%
Assets 1.3B USD -2.8%
Liabilities 603M USD -0.69%
Accumulated Other Comprehensive Income (Loss), Net of Tax -406K USD -130%
Retained Earnings (Accumulated Deficit) 56.2M USD -17.8%
Stockholders' Equity Attributable to Parent 699M USD -4.48%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 712M USD -4.34%
Liabilities and Equity 1.3B USD -2.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 14.3M USD +100%
Net Cash Provided by (Used in) Financing Activities -4.34M USD +70.4%
Net Cash Provided by (Used in) Investing Activities -2.26M USD +14.8%
Common Stock, Shares Authorized 1.12B shares 0%
Common Stock, Shares, Issued 188M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7.7M USD
Deferred Tax Assets, Valuation Allowance 21.9M USD +0.16%
Depreciation 51.4M USD +2.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -14M USD +28.2%
Lessee, Operating Lease, Liability, to be Paid 161M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 28.6M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 28M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 29.2M USD
Deferred Tax Assets, Operating Loss Carryforwards 20.9M USD +0.24%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 29.8M USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%